Angina is a clinical syndrome with symptoms attribute to myocardial ischaemia, most
commonly related to underlying occlusive coronary artery disease. There are many class of …

The objective of present investigation was to develop a extended release matrix tablet for
Ranolazine in the treatment of chronic angina pectoris using wet granulation technology …

Ranolazine is a clinically effective antianginal agent that has been used as the sodium-
dependent calcium ion influx inhibitor and inhibits the transmembrane influx of calcium ions …

Objectives: The objective of the current study was to develop an extended release (XR)
tablet formulation for ranolazine using Eudragit L 100-55 and hydroxypropylmethylcellulose …

Sustained-release drug delivery system containing Ranolazine (an anti-anginal drug) with
different ratios of pH dependent polymer, Eudragit L100-55 was designed by wet …

Current therapies those alleviate angina frequency and increase the threshold at which
demand-induced myocardial ischemic symptoms become evident include drugs (nitrates, β …

The objective of this study was to prepare and characterize swellable microspheres of
Ranolazine giving sustained release for chronic stable angina. Swellable microspheres …